Frontier Pharma - Small Cell Lung Cancer: Diverse First-in-Class Pipeline Shows Promise of Targeted Therapies to Treat Aggressive Disease

  • RnM3818116
    • |
  • 24 October, 2019
    • |
  • 55 Pages
    • |
  • GlobalData
    • |
  • Pharma & Healthcare

Request a Sample Report



Purchase this Report

$6,995.00
$13,990.00
$20,985.00
5,596.00
11,192.00
16,788.00
6,533.33
13,066.66
19,599.99
1,104,790.30
2,209,580.60
3,314,370.90
583,592.85
1,167,185.70
1,750,778.55
Credit card Logo

Reports and Markets

mcafree

Contact Us

+1-352-353-0818 (US)

info@reportsandmarkets.com

Support

EMAIL US

Newsletter

KEEP UP TO DATE ON ALL THE LATEST REPORTS


maxmind_logo